- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05601349
TeleEducation for Implementing a Clinical Practice Guideline For Amputees (TEFICA)
Effectiveness of a Telehealth-based Strategy to Improve the Implementation of the Clinical Practice Guide for Lower Limb Amputees by Neurovascular Disease and Trauma: Intervention Trial Randomised by Clusters
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The effectiveness of the educational program based on telehealth tools (TeleEducation: virtual course with recommendations from the CPG of lower limb amputees, at least four modules: Orthopedics, surgery, rehabilitation and prostheses; TeleAssistance: virtual conference between CPG researchers and professional from selected hospitals and delivery of educational material containing the recommendations of the CPG) compared to the usual socialization of the CPG in an informative meeting to the health personnel of the institutions, will be evaluated by means of a generalized estimated equation model (GEE) for dichotomous variables using the binomial distribution and logit as a link function since the outcomes that will be used will be handled with two coded response options 1 = satisfy 0 = does not satisfy and given the design of conglomerates where the measurements would be correlated.
The investigators are expecting to improve the implementation of the CPG be at least 15% higher than compare the intervention group with the control group.
The effectiveness of a telehealth based strategy is expected to improve the Implementation of the Clinical Practice Guide for diagnosis and preoperative treatment, intraoperative and postoperative period of the amputated person, the prescription of the prosthesis and the comprehensive rehabilitation in health institutions in Antioquia, Colombia, be at least 15% higher than compare the intervention group with the control group.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Antioquia
-
Medellín, Antioquia, Colombia, 050031
- Universidad de Antioquia
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Hospital providing medium and high complexity services in Antioquia that are linked or linked to the telehealth network of the University of Antioquia.
- Patients with lower limb amputation due to traumatic, vascular or diabetes mellitus that are treated in the aforementioned institutions.
- Health professionals who use CPG for people with amputation.
- Hospitals, patients and professionals who agree to participate in the project
Exclusion Criteria:
Patients who were amputated for other causes not included in the target population of the CPG, such as cancer and congenital.
- Amputee patients under 16 years.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Usual Implementation of the Clinical Practice Guideline
In this group, all participants (cluster) have access to the clinical practice guideline that has been sent to the office responsible for implementing the guideline in the hospital.
Due to the characteristics of the intervention in the control group it does not work as a placebo or a sham intervention.
|
Teleducation course, based on the CPG recommendations
|
|
Active Comparator: Tele-education strategy
Tele-educational program consisting of a virtual course with recommendations from the CPG of lower limb amputees, with three modules: Perioperative, rehabilitation and prostheses
|
Teleducation course, based on the CPG recommendations
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of patients who received two stages amputation in severe infection
Time Frame: 1 week
|
First stage for infection control and second stage for remodeling and definitive closure of the stump
|
1 week
|
|
Rate of patients who received perioperative analgesia
Time Frame: 72 hours
|
Perioperative epidural analgesia in patients who are going to be amputated from lower limbs to decrease acute pain of the stump and phantom limb in the period
|
72 hours
|
|
Rate of patients who received prophylactic antibiotics
Time Frame: 2 hours before the incision until 24 hours after the amputation
|
Antibiotic use (Cefazolin or Vancomycin in case of allergy to beta-lactams) from 2 hours before the incision until 24 hours after the amputation
|
2 hours before the incision until 24 hours after the amputation
|
|
Rate of patients who received transfemoral amputation instead of knee disarticulation
Time Frame: 24 hours
|
Transfemoral amputation instead of knee disarticulation
|
24 hours
|
|
Rate of patients who received myodesis
Time Frame: 24 hours
|
Myodesis (Suture of the adductor muscles to the bone through transosseous tunnels)
|
24 hours
|
|
Rate of patients who received immediate postoperative prosthesis
Time Frame: 24 hours
|
verify the order of the immediate prosthesis and if it was manufactured
|
24 hours
|
|
Rate of patients who received a SACH foot
Time Frame: 3 to 6 months
|
Adapt a solid ankle cushion heel (SACH) foot for amputations of the lower limbs above or below the knee and a low expected level of activity (K1 or K2)
|
3 to 6 months
|
|
Rate of patients who received an articulated foot
Time Frame: 3 to 6 months
|
adapt an articulated foot or a dynamic response foot in people with greater activity requirements (K3 / K4) or who must use the prosthesis on irregular or inclined surfaces
|
3 to 6 months
|
|
Rate of patients who received a prosthetic knee for above knee amputees
Time Frame: 3 to 6 months
|
Monocentric knee with manual locking or a knee with load brake in the K1 and monocentric or polycentric knee of fluid control in the K2, K3, K4 was prescribed
|
3 to 6 months
|
|
Rate of patients who received a prosthetic knee for knee disarticulated amputees
Time Frame: 3 to 6 months
|
mechanical polycentric knee was prescribed for disarticulation in K1 and polycentric fluid control for K2, K3, K4
|
3 to 6 months
|
|
Rate of patients who received occupational therapy
Time Frame: 3 to 6 months
|
occupational rehabilitation and ergonomic adaptations
|
3 to 6 months
|
|
Rate of patients who received comprehensive Rehabilitation
Time Frame: 2 weeks to 12 weeks
|
recommends the implementation of a comprehensive rehabilitation process: cardiopulmonary, musculoskeletal, psychosocial, activities of daily living and work
|
2 weeks to 12 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Jesús A Plata Contreras, Universidad de Antioquia
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- GrupoRS005
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
State University of New York at BuffaloMedical University of South CarolinaCompletedDiabetes Mellitus | Type 2 Diabetes Mellitus | Adult-Onset Diabetes Mellitus | Non-Insulin-Dependent Diabetes Mellitus | Noninsulin Dependent Diabetes Mellitus, Type IIUnited States
-
Hanmi Pharmaceutical Company LimitedUnknownType2 Diabetes Mellitus | Type1 Diabetes MellitusUnited States
-
Meir Medical CenterCompletedDiabetes Mellitus Type 2 | Diabetes Mellitus, Non-insulin Dependant | Diabetes Mellitus, on Oral Hypoglycemic Treatment | Adult Type Diabetes MellitusIsrael
-
Peking Union Medical College HospitalUnknownType 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Gestational Diabetes Mellitus | Pancreatogenic Diabetes Mellitus | Pregestational Diabetes Mellitus | Diabetes Patients in Perioperative PeriodChina
-
University of Colorado, DenverMassachusetts General Hospital; Ann & Robert H Lurie Children's Hospital of... and other collaboratorsRecruitingDiabetes Mellitus | Diabetes | Type 2 Diabetes | Diabetes Mellitus Type 2 | Diabetes Mellitus, Type I | Diabetes Mellitus Type II | Diabetes Mellitus, Insulin-Dependent | Diabetes, Autoimmune | Type 1 Diabetes (T1D) | Diabetes Type 2 on Insulin | Diabetes, Type IIUnited States
-
Medtronic MiniMed, Inc.RecruitingType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States, Australia, New Zealand
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Medical University of South CarolinaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
Clinical Trials on Telehealth-based strategy
-
Abramson Cancer Center at Penn MedicineNational Cancer Institute (NCI); National Institutes of Health (NIH)RecruitingTelemedicine | Decision Making | Early Detection of CancerUnited States
-
Vanderbilt University Medical CenterNational Center for Complementary and Integrative Health (NCCIH)CompletedChronic Low-back Pain | Postsurgical Pain | Lumbar Spine SurgeryUnited States
-
University Hospital, BrestTerminatedPulmonary EmbolismFrance, Switzerland, Canada
-
Indiana UniversityCompletedChildhood ObesityUnited States
-
VA Office of Research and DevelopmentRecruitingPeripheral Artery DiseaseUnited States
-
University of California, San FranciscoVisa FoundationCompletedCommunication | Parent-Child RelationsUnited States
-
Rutgers, The State University of New JerseyNational Institute on Aging (NIA)RecruitingAlzheimer's Disease (AD) | Healthy AgingUnited States
-
Cardiocentro TicinoUniversity of BernRecruitingChronic Coronary SyndromeSwitzerland
-
Fondazione Salvatore MaugeriCompleted
-
Wake Forest University Health SciencesDuke UniversityCompleted